Will generic pharmaceutical makers like Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) and Perrigo Company (NYSE:PRGO) continue to be a value play after Obamacare kicks...
Keep Reading →
August 12 - News
Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) has been stuck is share purgatory for a number of years.
Keep Reading →
August 6 - News
Maybe Texas just needs to fire up Ol' Sparky again.
Keep Reading →
August 5 - News
The investing waters can get pretty choppy from time to time with a developmental stage company. A look at the five-year chart of Momenta Pharmaceuticals, Inc.
Keep Reading →
August 2 - News
Hidden beneath all the numbers and metrics in Biogen Idec Inc (NASDAQ:BIIB)'s recent earnings report is a key confirmation of a shifting market in the treatment of multiple sclerosis...
Keep Reading →
August 1 - News
Taro Pharmaceutical Industries Ltd. (NYSE:TARO) hardly gets the attention it deserves.
Keep Reading →
August 1 - News
With the SPDR S&P Biotech Index up 29% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
Keep Reading →
July 29 - News
The United States Court of Appeals is making this one miserable summer for Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA).
Keep Reading →
July 29 - News
The recent rally in shares of Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) may suggest investors are regaining some confidence in this pharmaceutical manufacturer.
Keep Reading →
July 23 - News
The medical community certainly spends a lot of time and money researching treatments for cardiovascular disease and cancer.
Keep Reading →
July 15 - News
The real-money Inflation-Protected Income Growth portfolio just finished an astonishingly strong week, rising by more than $1,080 since the prior week's update to close with a...
Keep Reading →
July 15 - News
VIVUS, Inc. (NASDAQ:VVUS) has found an Italian to help it out.
Keep Reading →
July 10 - News
Investors love stocks that consistently beat the Street without getting ahead of their fundamentals and risking a meltdown.
Keep Reading →
July 10 - News
Recently, I enjoyed an article contributed by Adam Feuerstein ("AF article") regarding Antares Pharma Inc (NASDAQ:ATRS) and its transformational product Otrexup.
Keep Reading →
July 5 - News
It's hard to believe, but 2013 is already more than halfway over. This year has been a good one for many pharmaceutical stocks -- at least so far.
Keep Reading →
July 3 - News
Amgen, Inc. (NASDAQ:AMGN) has gone up a lot in share price over the last few years. Amgen, Inc.
Keep Reading →
July 1 - News
Cheap generic versions of Pfizer Inc. (NYSE:PFE)'s Viagra are coming to Europe, according the generic-drug maker Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA).
Keep Reading →
June 27 - News
A double-digit drop for Amgen, Inc. (NASDAQ:AMGN) stock over the past couple of months has likely left a bad taste in the mouths of shareholders.
Keep Reading →
June 25 - News
The healthcare sector has always been a subject of great interest to investors and analysts alike.
Keep Reading →
June 21 - News
A new Supreme Court ruling presents pharmaceutical companies with a tough choice -- stop paying generic-drug producers to withhold generic options from the market, or risk getting...
Keep Reading →
June 20 - News
Cancer is one of the deadliest challenges that humans face today. Different forms of cancer have taken millions of lives all around the world.
Keep Reading →
June 19 - News
Generic-drug makers are always on the hunt for the next branded drug to take down.
Keep Reading →
June 13 - News
Generic producers are often regarded as the safer players within BioPharma.
Keep Reading →
June 13 - News
Valeant Pharmaceuticals Intl Inc (NYSE:VRX) has been on an acquisition spree. Its latest purchase is Bausch + Lomb in an all-cash deal worth $8.7 billion.
Keep Reading →
June 12 - News
With one product already on the market, one recently approved and four more in various stages of clinical development, Biogen Idec Inc.
Keep Reading →
June 12 - News
The real-money Inflation-Protected Income Growth portfolio rose in value by a bit more than $245 since last week's update to end the week at $34,593.13.
Keep Reading →
June 10 - News
In late April, biotechnology firm Opko Health Inc.
Keep Reading →
June 6 - News
Editor's Note: Related tickers: Infosys Ltd ADR (NYSE:INFY), Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA), Marathon Petroleum Corp (NYSE:MPC), VIVUS, Inc.
Keep Reading →
June 5 - Hedge Funds
Tucked away inside Obamacare are 18 pages that could create a new $20 billion-per-year market.
Keep Reading →
June 4 - News
Valeant Pharmaceuticals Intl Inc (NYSE:VRX) has built a unique, winning drug business by acquiring underperforming niche product franchises and incorporating them into its efficient...
Keep Reading →
May 28 - News
Currently, a majority of pharma companies are facing the issue of generic competition.
Keep Reading →
May 28 - News
Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) was in 47 hedge funds' portfolio at the end of March. TEVA has experienced a decrease in hedge fund sentiment of late.
Keep Reading →
May 23 - News
Drug companies have been revenue generating machines for long.
Keep Reading →
May 22 - News
One of Pfizer Inc. (NYSE:PFE)'s best selling drugs is Viagra, which is used to treat erectile dysfunction.
Keep Reading →
May 21 - News
The real-money Inflation-Protected Income Growth portfolio saw yet another gain last week, this time picking up around $711 -- or better than 2.3% of the $30,000 it started with...
Keep Reading →
May 20 - News
Whether or not you've been keeping tabs, the American Society of Clinical Oncology's annual meeting is less than two weeks away.
Keep Reading →
May 20 - News
News that Montreal-based Valeant Pharmaceuticals Intl Inc (NYSE:VRX) was in talks to merge with Parsippany, New Jersey-based Actavis Inc (NYSE:ACT) emerged barely a week after...
Keep Reading →
May 15 - News
I follow quite a lot of companies, so the usefulness of a watchlist to me cannot be overstated.
Keep Reading →
May 15 - News
The first official recognition of Mother's Day occurred nearly a century ago, when on May 9, 1914, President Woodrow Wilson proclaimed the second Sunday in May would thereafter...
Keep Reading →
May 9 - News
Antares Pharma Inc (NASDAQ:ATRS) announced its first-quarter results Wednesday morning but failed to impress the market. Shares were down around 3% in midday trading.
Keep Reading →
May 8 - News
Actavis Inc (NYSE:ACT), the largest generic drug company in the US, just got even bigger.
Keep Reading →
May 1 - News
When it comes to biotechs, Amgen, Inc. (NASDAQ:AMGN) qualifies for the senior citizen discount.
Keep Reading →
April 24 - News
Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA), a pharmaceuticals company that makes money off of branded drugs as well as generics, is an interesting example of a company...
Keep Reading →
April 23 - News
I don't know about you, but I'm pretty stoked for the NFL draft this Thursday.
Keep Reading →
April 22 - News
On Tuesday, Amgen, Inc. (NASDAQ:AMGN) will release its latest quarterly results.
Keep Reading →
April 21 - News
Johnson & Johnson (NYSE:JNJ) has been considered a dividend growth star for a number of years now.
Keep Reading →
April 18 - News
Van Eck's Market Vectors unit, the fifth-largest U.S.
Keep Reading →
April 10 - Stock Analysis
Abbott Laboratories (NYSE:ABT) has begun its new future swimmingly.
Keep Reading →
April 5 - News
To most stock holders, hedge funds are assumed to be slow, outdated financial tools of the past.
Keep Reading →
April 1 - News
